Antenatal steroid treatment reduces childhood asthma risk in very low birth weight infants without bronchopulmonary dysplasia by Hung, Yi-Li et al.
J. Perinat. Med. 38 (2010) 95–102 • Copyright  by Walter de Gruyter • Berlin • New York. DOI 10.1515/JPM.2010.002
2010/212
Article in press - uncorrected proof
Original articles – Newborn
Antenatal steroid treatment reduces childhood asthma risk in
very low birth weight infants without bronchopulmonary
dysplasia
Yi-Li Hung1, Wu-Shiun Hsieh2, Hung-Chieh Chou2,
Yao-Hsu Yang2, Chien-Yi Chen2 and Po-Nien Tsao2,*
1 Department of Pediatrics, Cathay General Hospital,
Taipei, Taiwan
2 Department of Pediatrics, National Taiwan University
Hospital and National Taiwan University College of
Medicine, Taipei, Taiwan
Abstract
Bronchopulmonary dysplasia (BPD) and very low birth
weight (VLBW) are associated with increased incidences of
asthma and pulmonary dysfunction in childhood. However,
no studies exist which examine asthma risk factors in chil-
dren who were VLBW infants and did not have BPD. To
address this issue, we assessed the asthma incidence and risk
factors for asthma in 117 children (approximate mean age of
5 years) who were VLBW w-1500 g, mean gestational age
(GA): 30 weeksx infants without BPD. The risk factors were
both perinatal (such as steroid treatment, mechanical venti-
lation, surfactant treatment) and environmental (parental
smoking, pet adoption, etc). The asthma incidence was
18.8%. Following multivariate analysis, it was determined
that a family history of atopy was a strong risk factor for
childhood asthma. Maternal antenatal steroid treatment was
associated with a significantly reduced risk for asthma. GA
and birth weight were not predictive of childhood asthma.
These findings indicate that a history of familial atopy and
antenatal steroid treatment are positively and negatively asso-
ciated (independent of BPD) with childhood asthma in
VLBW infants. The finding regarding antenatal steroid treat-
ment warrants more extensive investigations.
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Advances in neonatal intensive care strategies and technol-
ogy markedly improved survival rates of very low birth
weight (VLBW) w12x. Despite this, bronchopulmonary dys-
plasia (BPD) remains a major morbidity in such infants w10,
31, 32x. There is also growing concern, and indeed compel-
ling evidence, about the long-term pulmonary consequences
for VLBW infants who had BPD w5, 12, 18x.
There appears to be a strong link between BPD and later
airway hyperresponsiveness in survivors w13x. There is also
evidence suggesting that prematurity/low birth weight per se
similarly leads to impaired lung development and pulmonary
dysfunction w4, 7, 15x. In addition, a number of studies have
reported an increased asthma risk in school-aged children
who were VLBW infants w23, 24x. In these studies, however,
it was not stated whether the VLBW infants were also afflict-
ed with BPD. Therefore, the aim of the present study is to
identify the perinatal and environmental risk factors associ-
ated with asthma and active wheezing in children who were
VLBW infants but did not suffer from BPD.
Materials and methods
We identified 158 children (aged 2–8 years) who were born preterm
between January 1995 and December 2001. All had been previously
admitted to our neonatal intensive care unit at F32 weeks’ gesta-
tional age (GA) with a birth weight -1500 g. Children with chro-
mosomal or congenital abnormalities, as well as those who suffered
BPD after birth, were excluded from the study. In the current study,
BPD was defined as the need for supplemental oxygen at a postnatal
age of 28 days with typical radiologic changes w2x, and respiratory
distress syndrome (RDS) was diagnosed by the clinical presentation
and changes on chest imaging w19x. Significant patent ductus arte-
riosus (PDA) included cases which required medical or surgical
intervention. A maternal history of clinical chorioamnionitis was
defined as one or more of the following: (i) persistent maternal fever
G37.58C on two or more occasions G1 h apart, or a single tem-
perature G388C, prior to delivery, (ii) maternal leukocytosis
G20,000/mL, or (iii) foul smelling amniotic fluid w34x. Postnatal
sepsis was specified as a positive blood culture with clinical symp-
toms or signs of infection. All participants were followed-up at our
outpatient clinics.
Parents of the enrolled children were invited by mail to answer
the International Study of Asthma and Allergies in Childhood
(ISAAC) Core Questionnaire Wheezing Module for 6–7 years chil-
dren (Table 1). Those who did not initially respond were sent a
second questionnaire. Children were categorized as having asthma
or not on the basis of ‘‘Yes’’ answers to questions 1 and 6. Children
with current active wheezing were those who had experienced
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Table 1 International study of asthma and allergies in childhood core questionnaire wheezing module for 6–7 years children.
No. Question Responses
1 Has your child ever had wheezing or whistling in the chest at Yes
any time in the past? No (skip to question 6)
Not sure
2 Has your child had wheezing or whistling in the chest in the last 12 months? Yes
No (skip to question 6)
Not sure




4 In the last 12 months, how often, on average, has your child’s sleep been disturbed Never
because of wheezing? -1 night per week
G1 nights per week
5 In the last 12 months, has wheezing ever been severe enough to Yes
disturb your child’s speech? No
Not sure
6 Has your child ever had asthma? Yes
No
Not sure
7 In the last 12 months, has your child’s chest sounded ‘‘wheezy’’ during or after exercise? Yes
No
Not sure
8 In the last 12 months, has your child had a dry cough at night, apart from a cough Yes
associated with a cold or a chest infection? No
Not sure
wheezing or chest whistling in the previous 12 months (i.e., ‘‘Yes’’
answers to questions 1 and 2). Night-time cough was indicated by
a ‘‘Yes’’ answer to question 8. Any answer of ‘‘Not sure’’ was
regarded as missing data in the statistical analysis.
Subject information pertaining to Apgar score at birth, antenatal
steroid treatment (dexamethasone 8 mg q8h for 1 day per course),
premature membrane rupture, RDS, chorioamnionitis, gestational
diabetes mellitus, preeclampsia, transient tachypnea of the newborn
(TTN), retinopathy of prematurity, intraventricular hemorrhage, sur-
factant therapy, mechanical ventilation duration, O2 utilization,
PDA, and sepsis was obtained by medical record review.
For each subject, we also collected information regarding family
history of atopy (allergic rhinitis or bronchial asthma in first-degree
relatives), passive exposure to tobacco smoke (defined as a family
member living with the child who currently smokes indoors), and
indoor feeding of cats or dogs.
Basic study subject characteristics (in both the asthma and non-
asthma groups) were first described by mean and standard deviation
(SD) or median (range) for continuous variables, and numbers for
categorical factors. Differences between groups for continuous and
categorical variables were assessed by independent t- and x2-tests.
If the number of any category was -5, Fisher’s exact tests were
performed. To assess the determinants of asthma occurrence, uni-
variate analyses by logistic regressions were applied to estimate the
relative risk of each variable for the diagnosis of asthma. Separate
multivariate analyses were then performed for GA and gender (these
factors displayed high co-linearity) with the various significant fac-
tors identified by univariate analyses as well as age at assessment
and gender. Birth weight and GA were assessed as categorical
variables, in tertiles. In tertiles, these two continuous variables were
categorized by 33% percentiles which transformed the small unit to
a bigger one, maximized statistical power, and made a test for trend
possible to detect a ‘‘dose-response relation’’. Odds ratios (ORs)
with 95% confidence intervals (CIs) were calculated to estimate the
relative risk of asthma. All statistical analyses were performed using
SPSS 13.0 for Windows. The significance level was set as 0.05.
Results
There was a 74% response rate (117 out of the 158 VLBW
infants identified) to the questionnaires. GA ranged from 22
to 32 weeks. Just -50% of the subjects were male. Those
who did not respond to the questionnaires were more likely
to suffer from retinopathy of prematurity compared with
those who completed the questionnaires. There were no sig-
nificant differences in other perinatal characteristics includ-
ing GA, birth weight, birth year, use of antenatal steroids,
RDS, PDA and sepsis episodes between the questionnaire
responders and non-responders. Of the 117 patients, 80
(68.4%) had received antenatal steroids and 63 of them com-
pleted at least one course of steroids 24 h before delivery.
Infants who received antenatal steroids had a significantly
lower incidence of severe RDS with surfactant therapy than
infants without antenatal steroids treatment (4/80 vs. 9/37,
Ps0.004). In our hospital, excluding uncontrolled premature
labor, all VLBW newborns were born by elective cesarean
section due to safety considerations. Therefore, 93 out of the
117 enrolled infants (79.5%) were born by cesarean section.
A total of 22 premature infants had TTN, but infants born
by cesarean section did not have a significantly higher risk
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Table 2 Basic comparisons in children with and without asthma who were very low birth weight infants (ns117).
Variables Asthma (ns22) No asthma (ns95) P-valuea
Age at assessment (months) 66.5 (24–99) 55.0 (24–107) 0.21
Gender
Male 11 46 0.89
Female 11 49
GA
1st tertile 6 36 0.61
2nd tertile 11 43
3rd tertile 5 16
Body birth weight
1st tertile 7 32 0.35
2nd tertile 5 34
3rd tertile 10 29
Small for gestational age
No 15 65 1.00
Yes 7 30
Total admission duration (days) 45.5 (25–75) 50.0 (22–114) -0.05c
5 min Apgar score -7b
No 21 80 0.30
Yes 1 14
Premature rupture of membrane
No 14 62 1.00
Yes 8 33
Antenatal steroid treatment
No 11 26 -0.05c
Yes 11 69
Transient tachypnea of the newborn
No 16 79 0.36
Yes 6 16
Respiratory distress syndrome
No 17 74 1.00
Yes 5 21
Surfactant therapyb
No 19 84 0.71
Yes 3 10
Mechanical ventilation (days) 0 (0–10) 0 (0–18) 0.80
Utilization of O2 )40% (days) 0 (0–2) 0 (0–6) 0.80
Total utilization of O2 (days) 1 (0–44) 3 (0–71) 0.86
Significant patent ductus arteriosusb
No 18 76 1.00
Yes 4 19
Sepsis during hospitalizationb
No 19 77 1.00
Yes 3 16
History of acute bronchiolitisb
No 13 79 -0.05c
Yes 9 16
Night cough
No 11 79 -0.01c
Yes 10 13
Family history of atopy
No 6 47 -0.05c
Yes 14 35
Smoking in family members
No 13 66 0.32
Yes 9 28
Pet adoptedb
No 22 83 0.12
Yes 0 12
Continuous variables are presented as median (range). Categorical variables are presented numerically.
aIndependent t-tests and x2-tests were performed for continuous and categorical variables.
bFisher’s exact tests were performed.
cIndicates a statistically significant difference between groups (P-0.05).
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of developing TTN compared with infants born by NSD
(20.4% vs. 12.5% Ps0.559).
Twenty-two of the children (18.8%) had asthma. Twenty-
five of the children (21.4%) had 31 hospitalizations for acute
bronchiolitis before age 2 years including 8 episodes of RSV.
Table 2 presents descriptive statistics for the study subjects
grouped according to whether or not they suffered from asth-
ma. The following variables were statistically different
between the groups: total admission duration, antenatal ster-
oid treatment, history of acute bronchiolitis, night cough, and
a family history of atopy. There were no statistically signif-
icant differences detected regarding GA or birth weight. In
an attempt to increase statistical power, tertiles (i.e., 33%
percentiles) were calculated and compared for these two con-
tinuous variables, however, there were still no significant dif-
ferences (Table 2). There were insufficient cases for analysis
of gestational diabetes mellitus, maternal preeclampsia, clin-
ical chorioamnionitis, retinopathy of prematurity and intra-
ventricular hemorrhage in each group.
The univariate analysis is presented in Table 3. There was
an increased risk of asthma detected for history of acute
bronchiolitis, night cough, family history of atopy and ante-
natal steroid treatment. As acute bronchiolitis and night
cough are asthma-related symptoms, rather than underlying
causes per se, they were not included as factors for the mul-
tivariate analyses.
As already noted, birth weight and gestation age at birth
were considered confounding factors and not included
together for multivariate analyses. Findings from the multi-
variate analysis including GA and the other factors of interest
are presented in Table 4. Antenatal steroid treatment and
family history of atopy remained significant risk factors.
With regards to the multivariate analysis incorporating birth
weight (Table 5), antenatal steroid exposure and family his-
tory of atopy were also found to be significant.
Discussion
While previous studies identified BPD and VLBW to be sig-
nificant risk factors for the development of later pulmonary
dysfunction and asthma, no studies to date have solely
assessed asthma risk factors in VLBW children who did not
suffer from BPD. In this study, we examined a cohort of
VLBW infants unaffected by BPD. We found that a family
history of atopy was a positive risk factor, and maternal ante-
natal steroid treatment a negative risk factor for later devel-
opment of asthma.
Asthma has become a leading cause of morbidity among
children over the past 20 years w33x. In southern Taiwan, the
prevalence of childhood asthma rose by ;30% from 1993
to 1997 w33x. Although the diagnosis of childhood asthma
lacks a standard criterion, the ISAAC Core Questionnaire can
provide useful, valid, and comparable data about the preva-
lence of asthma in children w27x. Using the ISAAC core
questionnaire, we found the incidence of asthma to be ;19%
in our VLBW population. This is in comparison to the world-
wide incidence of 10% w36x, and in Taiwan, 7% w21x. This
is significantly less than the rate reported by Ng et al. in
VLBW children (44%) w25x, but is comparable to that noted
by Palta and colleagues (19%) in VLBW children w26x. Asth-
ma was diagnosed using the ISAAC questionnaire in both of
these studies, and the children were of similar age to those
in our investigation (somewhat older in the Palta et al. study).
Although Ng et al. did not present information regarding
BPD w25x, presumably a high percentage of the studied
VLBW subjects were afflicted, thus explaining the very high
overall asthma incidence.
Respiratory morbidity, especially childhood asthma after
premature delivery, has a multifactorial etiology w17x. Airway
hyperresponsiveness and airway obstruction are consistently
found in children born prematurely, even in those without
neonatal pulmonary diseases, such as RDS or BPD w7, 8, 20,
30x. Whether this increased responsiveness is due to second-
ary neonatal lung injury or anatomically small airways is still
unclear w7, 27x. A number of previous studies have suggested
that there is an inverse relationship between GA and child-
hood asthma risk. For instance, Bernsen and colleagues
determined that asthma risk was inversely related to GA at
birth in 6-year-old children w3x. Gessner and Chimonas also
found that preterm birth was predictive of later asthma occur-
rence in children -10 years of age w16x. Contrary to these
studies, infants at the lower end of the GA spectrum were
no worse off than those at the higher end in terms of asthma
risk in our cohort of VLBW subjects. This suggests that there
might be a cut-off point for GA, where further decreases do
not result in a higher risk for asthma.
Other studies have suggested that birth weight per se rath-
er than GA is an important risk factor for later airway hyper-
responsiveness and asthma w20, 30x. Agosti and colleagues
found that asthma risk increased with decreasing birth weight
in VLBW infants w1x. However, the subjects were not dif-
ferentiated with respect to being afflicted with BPD. We did
not find that birth weight within our VLBW population was
predictive of childhood asthma. If indeed there is an effect
of birth weight on asthma susceptibility, our findings suggest
that within the VLBW categorization there is little variation.
Our study found that preterm infants with TTN did not
have a higher risk of developing childhood asthma. Contrary
to our findings, Birnkrant et al. found that TTN was inde-
pendently associated with childhood asthma, and they
hypothesized that TTN may be a marker of deficient pul-
monary function reflecting inherited susceptibility to asthma
w6x. A possible explanation for our difference is that our
enrolled candidates were all extremely premature infants
with immature pulmonary structure and function. It is diffi-
cult to distinguish TTN from mild RDS. In addition, our case
numbers were limited and a very small proportion of infants
were born vaginally. More studies are needed to establish
whether TTN in extremely preterm neonates relates to sub-
sequent childhood asthma.
A family history of atopy exerts antenatal effects on the
fetal immune system, causing a shift to responses biased
toward those of T helper 2 cells w11x. A parental (especially
maternal) history of allergy and asthma is widely accepted
Hung et al., Childhood asthma risk among VLBW infants without BPD 99
Article in press - uncorrected proof
Table 3 Risk factors for asthma in children who were very low birth weight infants as determined by univariate analyses (ns117).
Variables OR 95% CI P-value
Age at assessment (months) 1.01 0.99, 1.03 0.24
Gender
Male Ref – 0.89
Female 0.94 0.37, 2.37
Gestational agea
1st tertile Ref –
2nd tertile 1.54 0.52, 4.56 0.44
3rd tertile 1.88 0.50, 7.06 0.35
Body birth weightb
1st tertile Ref –
2nd tertile 0.67 0.19, 2.34 0.53
3rd tertile 1.58 0.53, 4.68 0.41
Small for gestational age
No Ref –
Yes 1.01 0.37, 2.74 0.98
Total admission duration (days) 0.98 0.95, 1.01 0.11
5 min Apgar score -7
No Ref –
Yes 0.27 0.03, 2.19 0.22
Premature rupture of membrane
No Ref –
Yes 1.07 0.41, 2.82 0.89
Antenatal steroid treatment
No Ref –
Yes 0.38 0.15, 0.97 -0.05c
Respiratory distress syndrome
No Ref –
Yes 1.04 0.34, 3.14 0.95
Surfactant therapy
No Ref –
Yes 1.33 0.33, 5.29 0.69
Mechanical ventilation (days) 0.99 0.87, 1.11 0.82
Utilization of O2 40% (days) 0.94 0.54, 1.65 0.84
Total utilization of O2 (days) 1.00 0.96, 1.04 0.86
Significant patent ductus arteriosus
No Ref –
Yes 0.89 0.27, 2.94 0.85
Sepsis during hospitalization
No Ref –
Yes 0.76 0.20, 2.88 0.69
History of acute bronchiolitis
No Ref –
Yes 3.42 1.25, 9.34 -0.05c
Night cough
No Ref –
Yes 5.52 1.96, 15.60 -0.01c
Family history of atopy
No Ref –
Yes 3.13 1.10, 8.97 -0.05c
Smoking in family members
No Ref –
Yes 1.63 0.63, 4.25 0.33
aP-value of test for trend: 0.33.
bP-value of test for trend: 0.39.
cIndicates a statistically significant risk factor.
ORsodds ratio, CIsconfidence interval.
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Table 4 Risk factor multivariate analysis (excluding birth weight) for asthma in children who were very low birth weight infants (ns117).
Variables OR 95% CI P-value
Gestational agea
1st tertile Ref –
2nd tertile 1.70 0.49, 5.94 0.41
3rd tertile 1.97 0.44, 8.85 0.38
Age at assessment (months) 1.01 0.99, 1.04 0.35
Gender
Male Ref –
Female 0.70 0.24, 2.06 0.52
Antenatal steroid treatment
No Ref –
Yes 0.27 0.08, 0.88 -0.05b
Family history of atopy
No Ref –
Yes 4.90 1.50, 15.96 -0.01b
aP-value of test for trend: 0.35.
bIndicates a statistically significant risk factor.
ORsodds ratio, CIsconfidence interval.
Table 5 Risk factor multivariate analysis (excluding gestational age) for asthma in children who were very low birth weight infants
(ns117).
Variables OR 95% CI P-value
Body birth weighta
1st tertile Ref –
2nd tertile 0.65 0.15, 2.74 0.56
3rd tertile 1.65 0.47, 5.82 0.44
Age at assessment (months) 1.01 0.99, 1.03 0.48
Gender
Male Ref –
Female 0.69 0.24, 2.05 0.51
Antenatal steroid treatment
No Ref –
Yes 0.23 0.06, 0.79 -0.05b
Family history of atopy
No Ref –
Yes 4.76 1.44, 15.68 -0.05b
aP-value of test for trend: 0.42.
bIndicates a statistically significant risk factor.
ORsodds ratio, CIsconfidence interval.
as a risk factor for persistent sensitization and childhood
asthma w11, 35x. In a previous population-based study in
southern Taiwan, a family history of atopy was obviously
associated with childhood asthma (ORs3.237) w33x. Ber-
trand et al. w4x and Evans et al. w14x had similar findings, as
have Palta et al. w26x in a study of VLBW children. In keep-
ing with these findings, we noted a strong association
between familial atopy and asthma risk in our population of
VLBW subjects.
An unexpected finding in our study was that antenatal
maternal steroid therapy was an independent protective fac-
tor against childhood asthma in children who were VLBW
infants. Such a finding has not been previously reported.
Contrary to our findings, Grischkan et al. found that there
was an increased risk for asthma in 8–11-year-old children
who were born preterm (F36 weeks) and treated with post-
natal steroids w17x, whereas Palta et al. reported a borderline
significant protective effect of antenatal steroid treatment on
wheezing in 8-year-old VLBW children w26x. Dalziel et al.
found that antenatal exposure to a single course of betame-
thasone dose not alter prevalence of wheezes and asthma at
age 30 years, but only 14% of their participants were born
at -1500 g w9x. From these findings (including ours) it
would appear that antenatal and postnatal steroid treatment
might have differing effects on asthma risk. A likely expla-
nation for our finding is that antenatal steroid therapy may
have enhanced lung maturation and therefore minimized sec-
ondary pulmonary injury caused by mechanical ventilation
and supplemental oxygen. Indeed, antenatal steroids are well
known to reduce the occurrence of RDS w22, 28, 29x. Addi-
tional studies in different populations are warranted to further
explore the impact of steroid treatment on asthma prevalence.
Hung et al., Childhood asthma risk among VLBW infants without BPD 101
Article in press - uncorrected proof
There is some limitation to our study. Because asthma may
be difficult to identify in children with previous BPD, our
study excluded infants with BPD and we required both a
doctor’s diagnosis and current wheezes to be classified as
asthmatic. However, because analyses were based on chil-
dren born prematurely with a wide range of ages (from 2 to
8 years) at assessment, we cannot determine whether or not
these perinatal effects on asthma are primarily mediated
through increased susceptibility to lower respiratory tract
infections during infancy. Further investigations should be
done to differentiate infection related wheeze from atopic
wheeze in these children.
In summary, we have presented an analysis of the risk
factors for childhood asthma in VLBW children without
BPD. We demonstrated that maternal antenatal steroid treat-
ment was associated with a protective effect in terms of asth-
ma occurrence whereas a familial history of atopy was
predictive for childhood asthma in our cohort. The finding
regarding the protective effect of antenatal steroids warrants
further investigation in other populations, including those
who suffered BPD after birth.
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